# Seizure Therapy With Intravenous Levetiracetam and Lorazepam

> **NCT00465244** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Seizures

## Interventions

- **DRUG:** Levetiracetam 1 g IV + Lorazepam 2 mg IV
- **DRUG:** Placebo + Lorazepam 3 mg IV

## Key facts

- **NCT ID:** NCT00465244
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-01
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Inability to recruit subjects
- **Last updated:** 2012-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00465244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00465244, "Seizure Therapy With Intravenous Levetiracetam and Lorazepam". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00465244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*